Lambert Nicole

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 33% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Lambert Nicole's trades of Myriad Genetics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
90.70
Quantity 40,291 +6.3%
Value US$3,209,971
Transaction date
Proposed sale
Price
389.43
Quantity 47,575
Value US$629,546
Transaction date
Planned sale
Price
29.84
Quantity 13,090 +49.3%
Value US$781,151
Transaction date
Proposed sale
Price
22.74
Quantity 13,184
Value US$299,822
Transaction date
Planned sale
Price
31.57
Quantity 1,420 -0.8%
Value US$44,835
Transaction date
Planned sale
Price
33.10
Quantity 10,112 -5.4%
Value US$334,747
Transaction date
Sale
Price
19.73
Quantity 4,354 -6.9%
Value US$85,915
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-28 2023-03-27
PlS Planned sale
40,291 +6.3%
90.70
US$3,209,971 		40,291 +6.3% 90.70 US$3,209,971
2023-03-27 2023-03-27
PrS Proposed sale
47,575
389.43
US$629,546 		47,575 389.43 US$629,546
2023-03-03 2023-03-02
PlS Planned sale
13,090 +49.3%
29.84
US$781,151 		13,090 +49.3% 29.84 US$781,151
2023-03-02 2023-03-02
PrS Proposed sale
13,184
22.74
US$299,822 		13,184 22.74 US$299,822
2021-10-04 2021-10-01
PlS Planned sale
1,420 -0.8%
31.57
US$44,835 		1,420 -0.8% 31.57 US$44,835
2021-09-27 2021-09-27
PlS Planned sale
10,112 -5.4%
33.10
US$334,747 		10,112 -5.4% 33.10 US$334,747
2020-02-12 2020-02-12
S Sale
4,354 -6.9%
19.73
US$85,915 		4,354 -6.9% 19.73 US$85,915